Stay up to date with all the major news, events and opportunities from the pharmaceutical and medical world by subscribing to my LinkedIn Newsletter here: newsletter.pharmemed.com #obesity #GLP1 #EliLilly #weightloss #pharma Exciting step forward from Lilly
For example, endocannabinoids and ghrelin stimulate the release and increase the activity of each other, leading to a synergistic effect 57,82
The treatment works by sending mild electric signals and stimulating the nerve fibers that are often involved in the setting of restless leg syndrome, says Avidal
IRL Advertising Is Helping GLP-1 Brands Go Mainstream January 15, 2026 In 1961, a New York housewife and mother named Jean Nidetch had a revolutionary idea: theres got to be a better way to lose weight
Read the full article here
In a post hoc analysis using pooled data from five trials (SURPASS-1 to -5) in people with type 2 diabetes and urinary albumin-to-creatinine ratio of 3.4 mg/mmol and above, tirzepatide was associated with a 19 to 26% reduction (depending on dose used) in urinary albumin-to-creatinine ratio compared with placebo or insulin
